海王生物(000078.SZ):轉讓控股子公司股權被動形成對外財務資助
格隆匯8月14日丨海王生物(000078.SZ)公佈,因市場情況發生變化,經公司與各方友好協商,公司控股子公司廣東海王集團與朱翰浩、廣西海王的小股東龍睿(廣州)生物科技有限公司簽訂了《股權轉讓協議》,由朱翰浩收購廣東海王集團持有的廣西海王65%股權。股權轉讓完成後,廣東海王集團不再持有廣西海王的股權,廣西海王不再是公司合併範圍內的子公司。
廣西海王作爲廣東海王集團子公司存續期間,廣東海王集團爲支持其日常經營向其提供往來資金,廣西海王尚欠廣東海王集團借款本金270萬元及利息,本次股權轉讓後被動形成公司對外提供財務資助,該項業務實質爲公司對原合併報表範圍內子公司提供日常經營性資金的延續。截至目前,廣西海王應向廣東海王集團歸還的借款本金270萬元及利息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.